This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Bowton, D. L. Articles by Coker, L. Search for Related Content PubMed PubMed Citation Articles by Bowton, D. L. Articles by Coker, L.

Stroke, Vol 20, 1662-1666, Copyright © 1989 by American Heart Association

ARTICLES

Pentoxifylline increases cerebral blood flow in patients with cerebrovascular disease

DL Bowton, DA Stump, DS Prough, JF Toole, DS Lefkowitz and L Coker
Department of Anesthesia (Critical Care), Wake Forest University Medical Center, Winston-Salem, North Carolina.

We determined the immediate effects of pentoxifylline on cerebral blood flow in 10 patients with cerebrovascular disease; four received 400 mg and six received 800 mg pentoxifylline orally. Regional cerebral blood flow was measured before (baseline) and 2, 4, and 6 hours after pentoxifylline administration using the xenon-133 clearance technique with 16 detectors (eight per hemisphere). Global cerebral blood flow as a percentage of the baseline value increased significantly after 800 mg but not 400 mg pentoxifylline (p = 0.017 and p = 0.29, respectively). Regional cerebral blood flow as a percentage of the baseline value at the detector with the lowest baseline value increased significantly 2 hours after both 400 mg and 800 mg pentoxifylline (p = 0.038 and p = 0.010, respectively). Cerebrovascular reactivity to carbon dioxide was preserved despite the increases in cerebral blood flow. Pentoxifylline increases cerebral blood flow and is not associated with "intracerebral steal" in patients with cerebrovascular disease.